Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CXCL2 |
| Upstream (Parents) |
|---|
| (<<) AQP3 → CXCL2 |
| (<<) CBS → CXCL2 |
| (<<) GOT1 → CXCL2 |
| (<<) HSD11B1 → CXCL2 |
| (<<) HSD17B2 → CXCL2 |
| (<<) HYAL1 → CXCL2 |
| (<<) MT1G → CXCL2 |
| (<<) MT1P2 → CXCL2 |
| (<<) NNMT → CXCL2 |
| (<<) RBKS → CXCL2 |
| (<<) RDH16 → CXCL2 |
| (<<) RORA → CXCL2 |
| (<<) SAA4 → CXCL2 |
| (<<) ST3GAL6 → CXCL2 |
| Downstream (Children) |
|---|
| CXCL2 → ADCY3 (>>) |
| CXCL2 → ATIC (>>) |
| CXCL2 → CEBPD (>>) |
| CXCL2 → CSNK1E (>>) |
| CXCL2 → CXCL1 (>>) |
| CXCL2 → EPN3 (>>) |
| CXCL2 → NRG1 (>>) |
| CXCL2 → PTGER4 (>>) |
| CXCL2 → SEPW1 (>>) |
| CXCL2 → SLPI (>>) |
| CXCL2 → SOCS2 (>>) |
| CXCL2 → SOD2 (>>) |
| CXCL2 → ST3GAL1 (>>) |
| CXCL2 → TPM4 (>>) |
| CXCL2 → TRIM32 (>>) |
